journal article·2024

Visible light degradable micelles for intraocular corticosteroid delivery

Ronghui Qi, Emily Mundy, Brian G. Amsden

Journal of Materials Chemistry B· Volume 12· Issue 8
Publisher page

Abstract

Visible light responsive micellar drug delivery formulations are of notable interest for the treatment of ocular diseases, as their successful development would enable controlled drug release at the back of the eye, improving efficacy and reducing side-effects when compared to existing approaches. In this work, an aliphatic polycarbonate-based visible light responsive micelle formulation based on mPEG-b-poly(5-hydroxy-trimethylene carbonate) (PHTMC) was prepared wherein the pendant hydroxyl groups of the PHTMC repeating units were protected by blue light-labile [7-(diethylamino)coumarin-4-yl]methyl (DEACM). The photo-labile DEACM provided a photo-triggered release profile, as, upon the removal of these protecting groups by photo-irradiation, the micelles underwent structural disruption, leading to the release of the payload. The removal of DEACM also deprotected the pendant hydroxyl groups of PHTMC, leading to PHTMC backbone degradation via intramolecular cyclization.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, Queen's University, Kingston, ON, Canada, K7L 3N6

Funding

Natural Sciences and Engineering Research Council of Canada

References (55)

Show source-provided references
1. Mandal · J. Controlled Release · 2017 · 248 · 9610.1016/j.jconrel.2017.01.012 ↗
2. Grimaudo · Expert Opin. Drug Delivery · 2019 · 16 · 39710.1080/17425247.2019.1597848 ↗
3. Savic · Science · 2003 · 300 · 61510.1126/science.1078192 ↗
4. Luo · Bioconjugate Chem. · 2002 · 13 · 125910.1021/bc025524y ↗
5. Allen · Biochim. Biophys. Acta, Biomembr. · 1999 · 1421 · 3210.1016/S0005-2736(99)00108-X ↗
6. Fomina · Adv. Drug Delivery Rev. · 2012 · 64 · 100510.1016/j.addr.2012.02.006 ↗
7. Sood · Drug Delivery · 2016 · 23 · 75810.3109/10717544.2014.940091 ↗
8. Christie · Drug Discovery Today · 2008 · 13 · 12410.1016/j.drudis.2007.12.005 ↗
9. Di Tommaso · Eur. J. Pharm. Biopharm. · 2012 · 81 · 25710.1016/j.ejpb.2012.02.014 ↗
10. Roberts · J. Photochem. Photobiol., B · 2001 · 64 · 13610.1016/S1011-1344(01)00196-8 ↗
11. Mura · Nat. Publ. Gr. · 2013 · 12 · 991
12. K.Barat , Laser Safety, Tools and Training , CRC press , 201410.1201/b16581 ↗
13. Rwei · Nano Today · 2015 · 10 · 45110.1016/j.nantod.2015.06.004 ↗
14. Elamri · J. Am. Chem. Soc. · 2021 · 143 · 1059610.1021/jacs.1c02817 ↗
15. Stegmaier · Langmuir · 2008 · 24 · 1187210.1021/la802052u ↗
16. Goguen · J. Am. Chem. Soc. · 2011 · 133 · 1103810.1021/ja2028074 ↗
17. Eckardt · J. Org. Chem. · 2002 · 67 · 70310.1021/jo010692p ↗
18. Babin · Angew. Chem., Int. Ed. · 2009 · 48 · 332910.1002/anie.200900255 ↗
19. Feng · Polymers · 2020 · 12 · 110.3390/polym12102268 ↗
20. Liang · Biomaterials · 2016 · 100 · 7610.1016/j.biomaterials.2016.05.023 ↗
21. Fratoddi · Nano Res. · 2015 · 8 · 177110.1007/s12274-014-0697-3 ↗
22. Chen · Polym. Degrad. Stab. · 2018 · 158 · 8310.1016/j.polymdegradstab.2018.10.022 ↗
23. Mohajeri · Int. J. Pharm. · 2020 · 590 · 11996510.1016/j.ijpharm.2020.119965 ↗
24. Mohajeri · Mol. Pharmaceutics · 2020 · 17 · 136310.1021/acs.molpharmaceut.0c00064 ↗
25. Alami-Milani · Pharm. Dev. Technol. · 2019 · 24 · 68010.1080/10837450.2019.1578370 ↗
26. Delcroix · Macromolecules · 2010 · 43 · 882810.1021/ma101461y ↗
27. Mespouille · Prog. Polym. Sci. · 2014 · 39 · 114410.1016/j.progpolymsci.2014.02.003 ↗
28. Brissenden · J. Polym. Sci. · 2020 · 58 · 269710.1002/pol.20200371 ↗
29. Tong · Bioconjugate Chem. · 2010 · 21 · 11110.1021/bc900356g ↗
30. Lu · Physiol. Behav. · 2011 · 176 · 139
31. de Gálvez · J. Photochem. Photobiol., B · 2022 · 228 · 11240510.1016/j.jphotobiol.2022.112405 ↗
32. Iseli · Graefes Arch. Clin. Exp. Ophthalmol. · 2016 · 254 · 10910.1007/s00417-015-3213-x ↗
33. Sharifpoor · Eur. J. Pharm. Biopharm. · 2007 · 65 · 33610.1016/j.ejpb.2006.09.008 ↗
34. Zhu · Macromolecules · 1991 · 24 · 173610.1021/ma00008a008 ↗
35. Liu · Adv. NanoBiomed Res. · 2022 · 2 · 220001710.1002/anbr.202200017 ↗
36. Yang · Biomacromolecules · 2014 · 15 · 134610.1021/bm4018879 ↗
37. Wang · J. Controlled Release · 2016 · 230 · 6410.1016/j.jconrel.2016.03.035 ↗
38. Lübtow · Biomacromolecules · 2019 · 20 · 304110.1021/acs.biomac.9b00618 ↗
39. Owen · Nano Today · 2012 · 7 · 5310.1016/j.nantod.2012.01.002 ↗
40. Ghezzi · J. Controlled Release · 2021 · 332 · 31210.1016/j.jconrel.2021.02.031 ↗
41. Zhang · Optom. Vis. Sci. · 2015 · 92 · 87310.1097/OPX.0000000000000642 ↗
42. T. C.Litzinger and K.Del Rio-Tsonis , Eye Anatomy . Encyclopedia of Life Sciences , 2002
43. Van Norren · Photochem. Photobiol. · 2011 · 87 · 74710.1111/j.1751-1097.2011.00921.x ↗
44. Timbart · Macromol. Biosci. · 2009 · 9 · 78610.1002/mabi.200800318 ↗
45. Varela-Fernández · Pharmaceutics · 2020 · 12 · 110.3390/pharmaceutics12030269 ↗
46. Heikkinen · Prog. Retinal Eye Res. · 2017 · 57 · 13410.1016/j.preteyeres.2016.12.001 ↗
47. Lu · J. Pharm. Sci. · 2013 · 102 · 62710.1002/jps.23390 ↗
48. Wu · Sci. Rep. · 2015 · 5 · 1355310.1038/srep13553 ↗
49. Gaballa · Drug Delivery Transl. Res. · 2021 · 11 · 86610.1007/s13346-020-00843-z ↗
50. Durgun · J. Ocul. Pharmacol. Ther. · 2020 · 36 · 32310.1089/jop.2019.0109 ↗
51. Talelli · Nano Today · 2015 · 10 · 9310.1016/j.nantod.2015.01.005 ↗
52. Anh · J. Controlled Release · 2015 · 200 · 7110.1016/j.jconrel.2015.01.001 ↗
53. Fomina · J. Am. Chem. Soc. · 2010 · 132 · 954010.1021/ja102595j ↗
54. Long · Adv. Sci. · 2021 · 8 · 1
55. Wang · Nat. Commun. · 2019 · 10 · 80410.1038/s41467-019-08690-4 ↗